Document is current

Article History

Accepted: 3 July 2026

First Online: 30 July 2026

Ethics

Competing interests: P.H. has received sessional fees from the Australian Medical Council, Health Education and Training Institute (HETI, NSW), and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education and BioMed Central; has prepared a report under contract for Takeda (formerly Shire) Pharmaceuticals regarding BED (July 2017); was a consultant to Takeda Pharmaceuticals; is a consultant to Tryptamine Pharmaceuticals; and is Chair of the Steering Committee of the National Eating Disorders Collaboration. All views expressed in this paper are her own. J.C.A. receives or has received research grants or consultancy fees from Takeda and Merck Pharmaceuticals; received research grants from the Brazilian National Council of Research (CNPq); receives royalties or honoraria from Artmed Editora; and is Chair of the Brazilian Clinical Practice Guidelines Project Working Group (Eating Disorders) of the Brazilian Association of Psychiatry. All views expressed in this paper are his own. A.K. has received honoraria from Takeda and Lunbeck for educational grants and speaker events. All views expressed in this paper are his own. E.S., K.E.G., T.S., U.S. and D.M. declare no competing interests.